The word “Amicogen” consists of the meaning of friend, “AMICO”
in Latin and of gene, “GENE”. We developed innovative biocatalysts
and proteins by applying our proprietary i DNA Evolution™ Technology.
We are a “Bioengineering company just like a Sincere Friend”
who contributes to the human health and the preservation of environment.
Amicogen Biotech R&D Center is expanding its R&D field based on
bio-platform technology, and researchers account for 30% of all employees.
We will lead the Industrial Biotechnology to develop new technologies
that can drive the development of humanity and society,
one step further than others.
Amicogen has developed Special Enzymes for industrial and pharmaceutical products based on the i DNA evolution™.
We want to contribute to the sustainable growth and lifelong health
of humanity by developing New Bio-Ingredientfor Health functional foods
with Special Enzymes and Protein Purification Resin.
As Amicogen started as a bio-venture company, we have focused on
the core competence of R&D and are pursuing sustainable growth
in innovative technologies and products. To increase the value
of enterprise and shareholder, we are continually strengthening our core competencies such as specialty enzyme business, healthcare, protein
purification resin business and others.
Amicogen promotes various activities to realize the value of contributing
to the protection of human health and the environment.
Amicogen is positioning itself as a global biotechnology company
through growth and leaps to create new values.
Amicogen has developed bio innovative technologies and operated the businesses that consider humankind and environment from the perspective of sustainability for the past 20 years. We will continue sustainable development based on Amicogen's environmental soundness, social responsibility and sustainable innovative technology.
Amicogen produces new technologies and values based on
creative thinking and constant technological innovation through human
oriented management. We do our best to ensure that talented individuals
with unique skills and abilities can demonstrate their abilities
according to the nature of their duties.
Amicogen produces new technologies and values based on
creative thinking and constant technological innovation through human
oriented management. We do our best to ensure that talented individuals
with unique skills and abilities can demonstrate their abilities
according to the nature of their duties.
Check out the various news from Amicogen,
which leads the Global Bio Industry with its best technology and outstanding competitiveness.
No. | Contents | |
---|---|---|
9 |
머니투데이에서 2014년 6월 18일 「아미코젠, 중국서 '특급칭찬' 받는 효소 기업-대우」를 보도하였습니다. [머니투데이] 기사보기 ▷ |
|
8 |
머니투데이에서 2013년 12월 02일 「아미코젠, R&D센타 신축에 16억 투자」를 보도하였습니다. [머니투데이] 기사보기 ▷ |
|
7 |
아미코젠, “페니실린계 항생제 합성 효소 개발 중 … 올해 실적 전망보다 줄 것” 경남신문에서 2013년 11월 18일 「신용철 아미코젠 대표, 진주서 과학특강」를 보도하였습니다. [경남신문] 기사보기 ▷ |
|
6 |
뉴스토마토에서 2013년 10월 11일 「아미코젠, 4억 규모 신주인수권 행사」를 보도하였습니다. [뉴스토마토] 기사보기 ▷ |
|
5 |
한국경제에서 2013년 9월 27일 「"아미코젠, 항생제 원료산업의 기린아"-대우」를 보도하였습니다. [한국경제] 기사보기 ▷ |
|
4 |
연합뉴스에서 2013년 9월 12일 「아미코젠㈜, 진주지역 기업 중 처음 코스닥 상장」를 보도하였습니다. [연합뉴스] 기사보기 ▷ |
|
3 |
뉴스토마토에서 2013년 9월 11일 「아미코젠, 코스닥 신규 상장 절차 완료」를 보도하였습니다. [뉴스토마토] 기사보기 ▷ |
|
2 |
이투데이에서 2013년 9월 3일 「아미코젠, 특수효소 만들어 자원고갈 막는다」를 보도하였습니다. [이투데이] 기사보기 ▷ |
|
1 |
뉴스핌에서 2013년 8월 29일 「[IPO] 아미코젠, 특수효소에서 원료의약품까지」를 보도하였습니다. [뉴스핌] 기사보기 ▷ |